Patients with high ferritin levels, increased splenomegaly, short height, and low body weight and patients in the high-risk group with low Ca, P, and vitamin 25 OH D levels and high ALP and PTH levels should be followed up more frequently. Here, PTH is linked to Splenomegaly.